Mercell Holding - Resolution to increase the share capital following exercise of options

Report this content

Oslo, 6 May 2021: The board of directors of Mercell Holding ASA (the "Company" or "Mercell") has in a board meeting held today, on 6 May 2021, resolved to increase the Company's share capital with NOK 77,469 by the issuance of 387,345 new shares, each with a nominal value of NOK 0.20 in order to facilitate an exercise of 387,345 options pursuant to the Company's share option program. The exercise price per new share pursuant to the share option program was NOK 1.50. The board of directors' resolution to increase the share capital of the Company was made pursuant to the authorisation granted to it by the general meeting on 22 April 2021.

Following the registration of the share capital increase with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret), the new share capital of the Company will be NOK 91,176,093.60, divided into 455,880,468 shares, each with a nominal value of NOK 0.20. The share capital increase will be registered with the Norwegian Register of Business Enterprises as soon as practically possible after the share contribution has been fully paid.

For further information please contact:

CFO Fredrik Eeg
Cell: +47 90 83 33 78
Email: Fredrik.eeg@mercell.com

This is Mercell:

Mercell is a leading digital platform for public eTendering and entered the eProcurement market in 2020. The company has approximately 2,200 pre-award buyers, 330 post-award buyers and some 26,600 suppliers as customers. Mercell's unique marketplace simplifies the tender and procurement process and makes it easy and secure for buyers to find relevant suppliers for their tenders and purchasing needs, and enables suppliers to find relevant business opportunities and receive and handle purchases from public and private buyers. Mercell delivers services to public and private buyers in 13 European countries with the goal of becoming the leading software-as-a-service (SaaS)-platform for eTendering and eProcurement in Europe. Through the acquisition of Negometrix in February 2021, Mercell also became market leader in the Netherlands and established a foothold in the US market.